Innoveren Scientific Inc. (IVRN)

Market Cap	18.22K
Revenue (ttm)	1.61M
Net Income (ttm)	-7.28M
Shares Out	n/a
EPS (ttm)	-30.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	54
Open	0.0036
Previous Close	0.0036
Day's Range	0.0040 - 0.0040
52-Week Range	0.0003 - 0.6950
Beta	471.76
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About IVRN

Innoveren Scientific Inc., a medical bioscience company that develops technology in regenerative medicine for limb salvage. It is also developing immunotherapies for ovarian cancer, pancreatic cancer, and mesothelioma. The company was formerly known as H-CYTE, Inc. and changed its name to Innoveren Scientific Inc. in July 2023. The company is headquartered in Tampa, Florida.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2013
• Employees: 2
• Stock Exchange: OTCMKTS
• Ticker Symbol: IVRN

Financial Performance

In 2022, IVRN's revenue was $453,460, a decrease of -71.86% compared to the previous year's $1.61 million. Losses were -$10.30 million, 114.6% more than in 2021.